PLC/PRF5

Cat.No.: CSC-C9581L

Species: Homo sapiens (Human)

Source: Liver

Morphology: epithelial-like

Culture Properties: monolayer

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C9581L
Description
HBV surface antigen secretion.
Species
Homo sapiens (Human)
Source
Liver
Recommended Medium
DMEM supplemented with 4.5 g/L glucose, 2 mM L-glutamine, and 10% h.i.FBS or SuperCult® PLC/PRF5 medium
Culture Properties
monolayer
Morphology
epithelial-like
STR DNA Profile
D3S1358:
vWA: 15,16
FGA: 19.2,25
Amelogenin: X
TH01: 7,8
TPOX: 8
CSF1P0: 10
D5S818: 12
D13S317: 11,12
D7S820: 9,11
Disease
Hepatocellular Carcinoma
Quality Control
Tests for mycoplasma, bacteria and fungi were negative
Storage and Shipping
Frozen with 52.5% RPMI-1640, 40% FBS, 7.5% DMSO at about 4-5 x 10^6 cells/ampoule; ship in dry ice; store in liquid nitrogen
Synonyms
PLC-PRF-5; PLC PRF 5; PLC/PRF5; PLCPRF5; PLC-8024; PLC8024; PLC; Alexander cells; Alexander; Primary Liver Carcinoma/Poliomyelitis Research Foundation/5
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

PLC/PRF/5 (AKA Alexander cells) is a human hepatocellular carcinoma (HCC) cell line that was originally established from the primary liver tumor of a 24-year-old man. It was one of the first human hepatocellular carcinoma cell lines shown to express hepatitis B virus (HBV) surface antigen (HBsAg), consistent with chronic HBV infection as an etiologic factor in human liver cancer. PLC/PRF/5 cells do not produce infectious viral particles but have integrated HBV DNA sequences that drive stable expression of HBsAg.

These cells have an epithelial-like, polygonal morphology and are adherent monolayer cells with distinct cell-cell borders. PLC/PRF/5 cells grow rapidly under standard tissue culture conditions, are typically maintained in MEM or DMEM media supplemented with fetal bovine serum, and maintain many hepatocyte-associated characteristics including expression of liver-specific proteins and metabolic enzymes. However, PLC/PRF/5 cells, like many tumor cells, are genetically unstable. At the molecular level, these cells harbor chromosomal abnormalities and mutations relevant to hepatocarcinogenesis, including alterations in pathways regulating cell cycle control, apoptosis, and oncogenic signaling. Thus, the PLC/PRF/5 cell line is useful for studying virus-host interactions and virus-associated carcinogenesis, in addition to being a model system for the study of the role of viral factors in the development of liver tumors.

The hepatocellular carcinoma cell line PLC/PRF/5 .

Fig. 1. The hepatocellular carcinoma cell line PLC/PRF/5(Li Y, Chen G, et al., 2020).

FAM50A Knockout Suppresses Growth and Survival in Hepatocarcinoma Cells

Hepatocellular carcinoma (HCC) is one of the most lethal malignancies with few effective therapies. FAM genes are candidate regulators of tumorigenesis, but their involvement in HCC is not well known. Here, Wu's team performed a comprehensive investigation on the expression profiles and functional roles of FAM genes in HCC.

The FAM50A expression level in different human hepatocarcinoma cells varied from 4.91 in HEPG2 to 8.12 in JHH2 (Fig. 1A). Knocking out of FAM50A greatly decreased the probability of cell survival lower than -0.5 in 11 hepatocarcinoma cells (Fig. 1B), indicating the critical role of FAM50A for HCC cell growth and survival. PLC/PRF5 cells, with intermediate FAM50A expression (7.27) and RNAi effect (-0.71), were chosen for further study. PLC/PRF5 cells were transfected with three siFAM50A sequences, significantly reducing FAM50A expression at both mRNA and protein levels (Fig. 1C and D). siFAM50A-1 showed the strongest inhibitory effect and was selected for subsequent experiments. CCK-8 and colony formation assays revealed reduced viability and proliferation in FAM50A-knockdown PLC/PRF5 cells (Fig. 2A and B). Scratch and Trans-well migration assays indicated impaired migration (Fig. 2C), and the Trans-well invasion assay showed fewer invasive cells in the siFAM50A group compared to controls (Fig. 2D).

Impact of FAM50A knockdown on hepatocarcinoma cell growth.

Fig. 1. Impact of FAM50A knockdown on hepatocarcinoma cell growth (Wu S, Chen S, et al., 2025).

Influence of reduced FAM50A expression on cellular functions.

Fig. 2. Influence of reduced FAM50A expression on cellular functions (Wu S, Chen S, et al., 2025).

Ask a Question

Write your own review

  • You May Also Need

For research use only. Not for any other purpose.

Hot Products